Comparing two nerve blocks for pain management after hip surgery
Comparison of Pericapsular Nerve Block and Iliopsoas Fascial Plane Block Effects on Postoperative Pain and Motor Weakness in Hip Surgery
This study is testing which of two types of nerve blocks can help reduce pain and keep movement better for people recovering from hip surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Haseki Training and Research Hospital Academic / other |
| Locations | 1 site (Istanbul, Sultangazi) |
| Trial ID | NCT06267716 on ClinicalTrials.gov |
What this trial studies
This prospective randomized interventional study compares the effectiveness of two types of peripheral nerve blocks, the pericapsular nerve block (PENG) and the iliopsoas block (IPB), in managing postoperative pain and preserving motor function after hip surgery. Participants will receive standardized general anesthesia and one of the two nerve blocks, with their pain levels and motor function evaluated over a 24-hour period. The goal is to determine which block provides better analgesia without causing motor weakness, thereby improving recovery outcomes for patients undergoing hip surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 90 who are undergoing total hip arthroplasty and have a BMI between 18 and 30.
Not a fit: Patients with neurological deficits, infections at the block site, or severe organ dysfunction may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing hip surgery, enhancing recovery and rehabilitation.
How similar studies have performed: While the iliopsoas block has been studied, the pericapsular nerve block has not been previously compared in randomized studies, making this approach novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients eligible for inclusion in this study were those aged 18 to 90 years who had undergone total hip arthroplasty surgery and had an American Society of Anesthesiologists (ASA) Physical Status classification of I to III and body mass index (BMI) between 18 and 30 kg/m2. Exclusion Criteria: * Patients were excluded if they had one of the following criteria: refusal to participate, a history of neurological deficits or neuropathy affecting the lower extremity, infection at the site of block application, coagulopathy; allergy to local anaesthetics, epilepsy or treatment with antipsychotics; abuse of alcohol or drugs; previous surgery distorting the anatomy of the inguinal or supra inguinal areas; severe organ dysfunction ( kidney, liver and other); uncooperative patients who fail to respond reliably to verbal pain assessment.
Where this trial is running
Istanbul, Sultangazi
- Haseki Training and Research Hospital — Istanbul, Sultangazi, Turkey (Recruiting)
Study contacts
- Principal investigator: Berna Caliskan, MD — Haseki Training and Research Hospital Anesthesiology and Reanimation Department
- Study coordinator: Berna Caliskan, MD
- Email: caliskan.b@gmail.com
- Phone: +905067108770
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.